Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Operating Income of $179.64 million for fiscal year 2025.
COLLEGIUM PHARMACEUTICAL, INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $179.64M | +5.7% |
| 2024 | $169.90M | +1.8% |
| 2023 | $166.96M | +401.1% |
| 2022 | $33.32M | +89.0% |
| 2021 | $17.63M | -68.7% |
| 2020 | $56.23M | +336.8% |
| 2019 | -$23.75M | -14.8% |
| 2018 | -$20.68M | +72.6% |
| 2017 | -$75.45M | +19.8% |
| 2016 | -$94.08M | -249.7% |
| 2015 | -$26.91M | -52.3% |
| 2014 | -$17.66M | -10.1% |
| 2013 | -$16.04M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $62.09M | +78.2% | +76.9% |
| June 30, 2025 | $35.10M | -26.0% | +61.9% |
| March 31, 2025 | $21.69M | -56.2% | -37.8% |
| September 30, 2024 | $34.84M | -22.6% | -26.6% |
| June 30, 2024 | $47.47M | +33.2% | -4.0% |
| March 31, 2024 | $49.47M | +100.9% | +9.9% |
| September 30, 2023 | $45.01M | +119.9% | +26.3% |
| June 30, 2023 | $35.63M | +220.7% | +44.7% |
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +5.7% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, COLLEGIUM PHARMACEUTICAL, INC’s operating income has grown by 1219.8% (from -$16.04 million to $179.64 million).
- The most recent figure is from COLLEGIUM PHARMACEUTICAL, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: